← Leaderboards
Ted M. Dawson
Johns Hopkins University
$31,695,689
Attributed
$41,877,834
Total exposure
30
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$80,655,744 · 31
By mechanism
P50$50,884,562 · 13
R01$9,635,000 · 4
U01$8,137,972 · 3
R37$5,347,689 · 1
RF1$4,002,525 · 1
R21$1,424,907 · 4
Top collaborators
- Valina L. Dawson14 shared
- Raymond C Koehler5 shared
- Akhilesh Pandey3 shared
- Alexander Y. Pantelyat2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Valina L. Dawson$28,150,357
- Christopher A Ross$35,771,871
- Wanli W Smith$8,415,706
- Hanseok Ko$8,865,346
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisParkinson DiseaseAlpha SynucleinPlayCessation Of LifeNeuronsLeadBrainCell DeathNeurodegenerative DisordersParkin Gene/ProteinCellsInvestigationResponsePreventResearch PersonnelProteinsNeuronal InjuryNerve DegenerationBaseDopaminergic NeuronEvaluationProgramsComplex
Grant awards (146)
MIF Nuclease actions in Synuclein Dementias$802,052
R01 · FY2025 · AG
Parthanatos, PAAN/MIF nuclease Activation in Ischemic Injury$673,291
R01 · FY2025 · NS · contact PI
MIF Nuclease actions in Synuclein Dementias$818,421
R01 · FY2024 · AG
Parthanatos, PAAN/MIF nuclease Activation in Ischemic Injury$654,684
R01 · FY2024 · NS · contact PI
Parthanatos, PAAN/MIF nuclease Activation in Ischemic Injury$674,932
R01 · FY2023 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$810,563
R37 · FY2021 · NS · contact PI
BIOMARKER DISCOVERY AND VALIDATION IN PSP$887,615
U01 · FY2020 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$810,563
R37 · FY2020 · NS · contact PI
Action of SARS CoV2 in Human Brain Cultures$542,592
RF1 · FY2020 · AG · contact PI
BIOMARKER DISCOVERY AND VALIDATION IN PSP$943,979
U01 · FY2019 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$810,563
R37 · FY2019 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$409,375
P50 · FY2019 · NS · contact PI
PARIS and site-specific DNA methylation in Parkinson's disease$62,225
P50 · FY2019 · NS · contact PI
Administrative Core$32,789
P50 · FY2019 · NS · contact PI
Transneuronal Propagation of Pathologic alpha-Synuclein from the Gut to the Brain Models Parkinson's Disease$1,500
P50 · FY2019 · NS · contact PI
Dynamics of synaptic connectivity in a mouse model of alpha-synuclein transmission$3,459,933
RF1 · FY2018 · AG · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$2,004,748
P50 · FY2018 · NS · contact PI
BIOMARKER DISCOVERY AND VALIDATION IN PSP$928,403
U01 · FY2018 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$729,000
R37 · FY2018 · NS · contact PI
Biomarker Discovery and Validation in Parkinson's Disease$644,960
U01 · FY2018 · NS · contact PI
Biology of Parkin and It's Role in Parkinson's Disease$340,808
P50 · FY2018 · NS · contact PI
Administrative Core$160,381
P50 · FY2018 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$2,004,748
P50 · FY2017 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$729,000
R37 · FY2017 · NS · contact PI
Biomarker Discovery and Validation in Parkinson's Disease$660,444
U01 · FY2017 · NS · contact PI
Biology of Parkin and It's Role in Parkinson's Disease$340,808
P50 · FY2017 · NS · contact PI
Administrative Core$160,381
P50 · FY2017 · NS · contact PI
2016 Udall Center Poster Award$1,500
P50 · FY2017 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$2,004,748
P50 · FY2016 · NS · contact PI
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease$877,149
U01 · FY2016 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$729,000
R37 · FY2016 · NS · contact PI
Biology of Parkin and It's Role in Parkinson's Disease$340,808
P50 · FY2016 · NS · contact PI
Administrative Core$160,381
P50 · FY2016 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$49,852
P50 · FY2016 · NS · contact PI
2015 Udall Center Poster Award$1,500
P50 · FY2016 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$2,004,748
P50 · FY2015 · NS · contact PI
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease$877,149
U01 · FY2015 · NS · contact PI
Parthanatos, AIF and PAAN-1 in Neuronal Injury$729,000
R37 · FY2015 · NS · contact PI
Biology of Parkin and It's Role in Parkinson's Disease$340,808
P50 · FY2015 · NS · contact PI
Administrative Core$160,382
P50 · FY2015 · NS · contact PI
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease$90,033
U01 · FY2015 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$2,500
P50 · FY2015 · NS · contact PI
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)$2,430,000
P50 · FY2014 · NS · contact PI
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease$868,377
U01 · FY2014 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$663,037
R01 · FY2014 · NS · contact PI
Biology of Parkin and It's Role in Parkinson's Disease$413,100
P50 · FY2014 · NS · contact PI
Administrative Core$194,400
P50 · FY2014 · NS · contact PI
The Morris K Udall Parkinson's Disease Research Center of Excellence$1,929,516
P50 · FY2013 · NS · contact PI
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease$750,071
U01 · FY2013 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$646,293
R01 · FY2013 · NS · contact PI
Biology of Parkin and Its Role in Parkinson's Disease$346,526
P50 · FY2013 · NS · contact PI
cell Function & Pathophysiology Project$168,926
U24 · FY2013 · NS · contact PI
Transgenic and Neurobehavior Core$149,879
P50 · FY2013 · NS · contact PI
Administrative Core$137,591
P50 · FY2013 · NS · contact PI
The Morris K Udall Parkinson's Disease Research Center of Excellence$2,015,585
P50 · FY2012 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$669,735
R01 · FY2012 · NS · contact PI
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease$609,792
U01 · FY2012 · NS · contact PI
Biology of Parkin and Its Role in Parkinson's Disease$358,348
P50 · FY2012 · NS · contact PI
cell Function & Pathophysiology Project$184,136
U24 · FY2012 · NS · contact PI
Transgenic and Neurobehavior Core$161,222
P50 · FY2012 · NS · contact PI
Administrative Core$148,478
P50 · FY2012 · NS · contact PI
The Morris K Udall Parkinson's Disease Research Center of Excellence$121,500
P50 · FY2012 · NS · contact PI
Biology of Parkin and Its Role in Parkinson's Disease$121,500
P50 · FY2012 · NS · contact PI
The Morris K Udall Parkinson's Disease Research Center of Excellence$2,032,598
P50 · FY2011 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$669,733
R01 · FY2011 · NS · contact PI
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.$411,177
P50 · FY2011 · DA · contact PI
Biology of Parkin and Its Role in Parkinson's Disease$360,225
P50 · FY2011 · NS · contact PI
Transgenic and Neurobehavior Core$162,581
P50 · FY2011 · NS · contact PI
Administrative Core$149,391
P50 · FY2011 · NS · contact PI
The Morris K Udall Parkinson's Disease Research Center of Excellence$2,029,946
P50 · FY2010 · NS · contact PI
Poly (ADP-Ribose) and AIF in Neuronal Injury$676,498
R01 · FY2010 · NS · contact PI
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.$429,236
P50 · FY2010 · DA · contact PI
Biology of Parkin and Its Role in Parkinson's Disease$358,637
P50 · FY2010 · NS · contact PI
Transgenic and Neurobehavior Core$162,370
P50 · FY2010 · NS · contact PI
Administrative Core$148,860
P50 · FY2010 · NS · contact PI
The Morris K Udall Parkinson's Disease Research Center of Excellence$2,005,748
P50 · FY2009 · NS · contact PI
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.$403,962
P50 · FY2009 · DA · contact PI
Biology of Parkin and Its Role in Parkinson's Disease$355,109
P50 · FY2009 · NS · contact PI
Transgenic and Neurobehavior Core$183,443
P50 · FY2009 · NS · contact PI
Administrative Core$156,249
P50 · FY2009 · NS · contact PI
The Role of Parkin in Parkinson's Disease$109,913
R01 · FY2009 · NS · contact PI
Parkinson's Disease Research Center of Excellence$99,963
P50 · FY2009 · NS · contact PI
Parkinson's Disease Research Center of Excellence$8,528
P50 · FY2009 · NS · contact PI
Parkinson's Disease Research Center of Excellence$2,276,452
P50 · FY2008 · NS · contact PI
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.$392,392
P50 · FY2008 · DA · contact PI
Mouse Models of Parkin Biology and Pathobiology$387,249
P50 · FY2008 · NS · contact PI
The Role of Parkin in Parkinson's Disease$358,502
R01 · FY2008 · NS · contact PI
Transgenic and Neurobehavior Core$256,459
P50 · FY2008 · NS · contact PI
Poly (ADP-Ribose) Signalling in Glutamate Excitotoxicity$73,345
P01 · FY2008 · NS · contact PI
Parkinson's Disease Research Center of Excellence$2,276,389
P50 · FY2007 · NS · contact PI
Mouse Models of Parkin Biology and Pathobiology$387,057
P50 · FY2007 · NS · contact PI
The Role of Parkin in Parkinson's Disease$358,502
R01 · FY2007 · NS · contact PI
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.$357,830
P50 · FY2007 · DA · contact PI
Transgenic and Neurobehavior Core$256,317
P50 · FY2007 · NS · contact PI
Reversible and Temporally Inducible LRRK2 Knockout Mice$214,706
R21 · FY2007 · NS · contact PI
JHMI Clinical Center for Parkinson's Disease Neuroprotection Trials$58,768
U10 · FY2007 · NS · contact PI
Poly (ADP-Ribose) Signalling in Glutamate Excitotoxicity$50,748
P01 · FY2007 · NS · contact PI
Parkinson's Disease Research Center of Excellence$2,276,100
P50 · FY2006 · NS · contact PI
The Role of Parkin in Parkinson's Disease$369,209
R01 · FY2006 · NS · contact PI
Mouse Models of Parkin Biology and Pathobiology$341,494
P50 · FY2006 · NS · contact PI
Transgenic and Neurobehavior Core$226,148
P50 · FY2006 · NS · contact PI
Models of Familial Parkinson's Disease: PINK1$184,463
R21 · FY2006 · NS · contact PI
Reversible and Temporally Inducible LRRK2 Knockout Mice$183,703
R21 · FY2006 · NS · contact PI
Parkinson's Disease Research Center of Excellence$40,875
P50 · FY2006 · NS · contact PI
Poly (ADP-Ribose) Signalling in Glutamate Excitotoxicity$36,855
P01 · FY2006 · NS · contact PI
JHMI Clinical Center for PD Neuroprotection Trials$12,700
U10 · FY2006 · NS · contact PI
Parkinson's Disease Research Center of Excellence$2,210,330
P50 · FY2005 · NS
The Role of Parkin in Parkinson's Disease$378,094
R01 · FY2005 · NS
Mouse Models of Parkin Biology and Pathobiology$331,550
P50 · FY2005 · NS
Transgenic and Neurobehavior Core$219,561
P50 · FY2005 · NS
Models of Familial Parkinson's Disease: PINK1$188,035
R21 · FY2005 · NS
Models of Familial Parkinson's Disease: DJ-1 Knockouts$163,500
R21 · FY2005 · NS
Poly (ADP-Ribose) Signalling in Glutamate Excitotoxicity$36,855
P01 · FY2005 · NS
Parkinson's Disease Research Center of Excellence$2,145,960
P50 · FY2004 · NS
The Role of Parkin in Parkinson's Disease$378,094
R01 · FY2004 · NS
Mouse Models of Parkin Biology and Pathobiology$321,894
P50 · FY2004 · NS
Transgenic and Neurobehavior Core$213,165
P50 · FY2004 · NS
Administrative &Training Core$190,273
P50 · FY2004 · NS
Models of Familial Parkinson's Disease: DJ-1 Knockouts$163,500
R21 · FY2004 · NS
Poly (ADP-Ribose) Signalling in Glutamate Excitotoxicity$36,855
P01 · FY2004 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$817,500
P50 · FY2003 · NS
Apoptosis Inducing Factor in Dopaminergic Cell Death$163,500
R21 · FY2003 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$81,750
P50 · FY2003 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$81,750
P50 · FY2003 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$1,823,325
P50 · FY2002 · NS
Apoptosis Inducing Factor in Dopaminergic Cell Death$163,500
R21 · FY2002 · NS
JHMI Clinical Center for PD Neuroprotection Trials$114,063
U10 · FY2002 · NS
CORE--TRANSGENIC AND NEUROBEHAVIOR FACILITY$88,647
P50 · FY2002 · NS
MOLECULAR MECHANISMS OF MPTP NEUROTOXICITY$88,647
P50 · FY2002 · NS
Excitotoxins and PARP in striatal vulnerability$0
P01 · FY2002 · NS
Core--Gene transfer$0
P01 · FY2002 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$1,770,218
P50 · FY2001 · NS
TRANSCRIPTIONAL REGULATION IN NEURONAL INJURY$372,023
R01 · FY2001 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$100,000
P50 · FY2001 · NS
CORE--TRANSGENIC AND NEUROBEHAVIOR FACILITY$88,647
P50 · FY2001 · NS
MOLECULAR MECHANISMS OF MPTP NEUROTOXICITY$88,647
P50 · FY2001 · NS
Core--Gene transfer$0
P01 · FY2001 · NS
CORE--TRANSGENIC AND NEUROBEHAVIOR FACILITY$0
P50 · FY2001 · NS
MOLECULAR MECHANISMS OF MPTP NEUROTOXICITY$0
P50 · FY2001 · NS
Excitotoxins and PARP in striatal vulnerability$0
P01 · FY2001 · NS
PARKINSONS DISEASE RESEARCH CENTER OF EXCELLENCE$1,718,658
P50 · FY2000 · NS
TRANSCRIPTIONAL REGULATION IN NEURONAL INJURY$361,987
R01 · FY2000 · NS
CORE--TRANSGENIC AND NEUROBEHAVIOR FACILITY$229,310
P50 · FY2000 · NS
MOLECULAR MECHANISMS OF MPTP NEUROTOXICITY$229,310
P50 · FY2000 · NS
Excitotoxins and PARP in striatal vulnerability$224,920
P01 · FY2000 · NS
Core--Gene transfer$224,918
P01 · FY2000 · NS